Read Complete Press Release Here RIDGEFIELD, Conn., November 23, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Pradaxa® (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip replacement surgery. There … Continue reading →
by Dr. Scott Rubinstein August 25, 2007 Hi All, Here we are debating a question that has no clear cut answer. All the anticoagulents have side effects. Bleeding and bruising are the most common ones. There are advantages and disadvantages to each and none is the clear cut winner. As far as effectiveness they all…
Continue reading →From the Hip Replacement Handbook by Brian McGrory Read More about Blood Clots Updated 7/5/08 By Brian McGrory Blood Clots Arteries are blood vessels that carry blood away from the heart to body tissues and organs. Veins are blood vessels through which blood travels from all parts of the body back to the heart. A…
Continue reading →Updated 7/5/08 Your doctor has prescribed anti-coagulation medications to prevent blood clots and increase the blood flow in your legs. Along with taking your medications as prescribed, T.E.D. anti-embolism stockings will help prevent blood clots in the deep veins of your legs. What are T.E.D. Anti-embolism stockings? Commonly referred to as TED or TEDS…
Continue reading →